Last updated on August 2019
A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions: Endogenous depression | Bipolar Disorder | Depression
-
Age: - 100 Years
-
Gender: Male or Female
Inclusion Criteria:
- Patients with depressive symptoms of bipolar disorder
- Patients who have previously not been treated with quetiapine fumarate (immediate-release formulations of quetiapine fumarate and Bipresso Extended-Release Tablets)
Exclusion Criteria:
- None